Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2016 042 385.5 |
96 | EP file number | EAKZ | 16 79 3259.9 |
86 | WO file number | WAKZ | PCT/US2016/031224 |
97 | EP publication number | EPN | 3294873 |
87 | WO publication number | WPN | 2016182917 |
54 | Designation/title | TI | ABZIELUNG AUF FUNKTIONELLE REGIONEN DES BCL11A-ENHANCERS ZUR REINDUKTION VON FETALEM HÄMOGLOBIN |
51 | IPC main class | ICM (ICMV) | C12N 15/10 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C12N 5/078 (2010.01), C12N 9/22 (2006.01), C12N 15/11 (2006.01), C12N 15/86 (2006.01) |
22 | DE application date | DAT | May 6, 2016 |
96 | EP application date | EAT | May 6, 2016 |
86 | WO application date | WAT | May 6, 2016 |
43 | Date of first publication | OT | Nov 17, 2016 |
| Date of publication of grant | PET | Aug 19, 2020 |
71/73 | Applicant/owner | INH | Massachusetts Institute of Technology, Cambridge, Mass., US; The Broad Institute, Inc., Cambridge, Mass., US; The Children's Medical Center Corporation, Boston, Mass., US |
72 | Inventor | IN | BAUER, Daniel E., Cambridge, Massachusetts 02138, US; ORKIN, Stuart H., Brookline, Massachusetts 02442, US; SANJANA, Neville, New York, New York 10012, US; SHALEM, Ophir, Merion Station, PA 19066, US; ZHANG, Feng, Cambridge, Massachusetts 02139, US |
| Address for service | | VALIPAT, 1050 Brussels, BE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201562158882 P May 8, 2015
|
| Due date | FT FG | May 31, 2025 Annual fee for the 10th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003294873A1 Searchable text:
EP000003294873A1 Original document:
EP000003294873B1 Searchable text:
EP000003294873B1 Original document:
EP000003294873B2 Searchable text:
EP000003294873B2 Original document:
WO002016182917 Searchable text:
WO002016182917 |
43 | Date of first publication | EVT | Nov 17, 2016 |
| Date of the first transfer into DPMAregister | EREGT | Mar 21, 2018 |
| Date of the (most recent) update in DPMAregister | REGT | Oct 18, 2024 (Show all update days)(Hide all update days)- Oct 18, 2024
- Address for service: changed
- Sep 19, 2024
- Procedures: Opposition procedure, Decision by EPO to maintain patent in amended form has become final, 18.09.2024: changed
- Aug 29, 2024
- Published EP/WO documents: changed
- Procedures: Opposition procedure, Patent maintained in amended form by EPO, 18.09.2024: new
- Procedures: Opposition procedure, Decision by EPO to maintain patent in amended form has become final, 18.09.2024: new
- Jun 8, 2024; May 9, 2024; Jun 7, 2023; Jun 9, 2022; Aug 21, 2021; Jun 24, 2021; Jun 10, 2021; Jun 8, 2021; Nov 20, 2020; Sep 10, 2020; Aug 4, 2020; Jul 30, 2020; May 24, 2018
- Historical data not available for this/these date(s)
- Mar 21, 2018
- Date of the first transfer into DPMAregister
|